Invesco
ORKA

Invesco’s Oruka Therapeutics ORKA Stock Holding History

Invesco’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.9M Buy
124,658
+27,616
+28% +$1.84M ﹤0.01% 1809
2026
Q1 		$4.76M Sell
97,042
-46,079
-32% -$1.6M ﹤0.01% 2220
2025
Q4 		$4.34M Buy
143,121
+126,803
+777% +$3.53M ﹤0.01% 2307
2025
Q3 		$314K Buy
16,318
+1,008
+7% +$14.9K ﹤0.01% 3400
2025
Q2 		$172K Buy
+15,310
New +$160K ﹤0.01% 3554
2014
Q1 		– Hold
0
– – – 4314
2013
Q4 		– Hold
0
– – – 4382
2013
Q3 		– Hold
0
– – – 4343
2013
Q2 		– Hold
0
– – – 4292

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Invesco's ORKA Position: Q2 2026 in Review

Invesco increased its Oruka Therapeutics (ORKA) stake by 28% in Q2 2026, buying an estimated $1.84M and bringing the position to 124,658 shares worth $11.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1809.

Invesco first reported a position in ORKA in Q2 2025 and has held it in 5 quarters since. 255 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Invesco held 124,658 shares of Oruka Therapeutics worth $11.9M as of Q2 2026.
  • Invesco bought 27,616 Oruka Therapeutics shares in Q2 2026, an estimated $1.84M.
  • Oruka Therapeutics made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #1809 holding.
  • Invesco first reported a position in Oruka Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 255 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.